首页 > 最新文献

Annales D Urologie最新文献

英文 中文
Complications chirurgicales de la transplantation rénale 肾移植的手术并发症
Pub Date : 2007-12-01 DOI: 10.1016/j.anuro.2007.08.007
G. Karam, F. Maillet, G. Braud, S. Battisti, J.-F. Hétet, P. Glémain, L. Le Normand, O. Bouchot, J. Rigaud

Kidney transplantation has become the treatment of choice for patients with end stage renal disease since it offers an excellent quality of life. Moreover, the economic impact is considerable, particularly beyond the first year. Indeed, the annual cost of a successful renal transplantation is ten fold lower than haemodialysis. But surgical complications remain one of our main concerns. Surgical complications are various. They may be non-specific as haematomas, incision-induced hernias and wound infections. They may also be directly related to the procedure as vascular thrombosis and urinary fistula in the early post-operative period or arterial stenosis and ureteral obstruction in the late post-operative period. The accurate diagnosis and the appropriate management of these complications are the most important tasks for the surgical team. This review is based upon our experience in kidney transplantation and upon the medical published data.

肾移植已成为终末期肾病患者的治疗选择,因为它提供了极好的生活质量。此外,经济影响是相当大的,特别是在第一年之后。事实上,一次成功的肾移植每年的花费比血液透析低十倍。但手术并发症仍然是我们主要关注的问题之一。手术并发症多种多样。它们可能是非特异性的,如血肿、切口引起的疝和伤口感染。它们也可能与手术直接相关,如术后早期的血管血栓形成和尿瘘,或术后晚期的动脉狭窄和输尿管梗阻。准确的诊断和适当的处理这些并发症是外科团队最重要的任务。这篇综述是基于我们在肾移植方面的经验和医学上发表的数据。
{"title":"Complications chirurgicales de la transplantation rénale","authors":"G. Karam,&nbsp;F. Maillet,&nbsp;G. Braud,&nbsp;S. Battisti,&nbsp;J.-F. Hétet,&nbsp;P. Glémain,&nbsp;L. Le Normand,&nbsp;O. Bouchot,&nbsp;J. Rigaud","doi":"10.1016/j.anuro.2007.08.007","DOIUrl":"10.1016/j.anuro.2007.08.007","url":null,"abstract":"<div><p>Kidney transplantation has become the treatment of choice for patients with end stage renal disease since it offers an excellent quality of life. Moreover, the economic impact is considerable, particularly beyond the first year. Indeed, the annual cost of a successful renal transplantation is ten fold lower than haemodialysis. But surgical complications remain one of our main concerns. Surgical complications are various. They may be non-specific as haematomas, incision-induced hernias and wound infections. They may also be directly related to the procedure as vascular thrombosis and urinary fistula in the early post-operative period or arterial stenosis and ureteral obstruction in the late post-operative period. The accurate diagnosis and the appropriate management of these complications are the most important tasks for the surgical team. This review is based upon our experience in kidney transplantation and upon the medical published data.</p></div>","PeriodicalId":50783,"journal":{"name":"Annales D Urologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.anuro.2007.08.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27421977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 49
Chirurgie urologique assistée par robot : principes généraux 机器人辅助泌尿外科:一般原则
Pub Date : 2007-12-01 DOI: 10.1016/j.anuro.2007.08.003
J. Hubert

Born in the late 90s, robotic-assisted laparoscopy has today an exponential growth. It presents some disadvantages, the first of them being a very high cost, similarly to all new medical technologies. On the other hand, its advantages are very important and allow the open surgeon to apply his natural skills to the endoscopic approach, while recovering the 3-dimensional vision. Urology is the specialty that has the most benefited from this new technology. If this technique progresses as rapidly as computers, it is likely to become associated to new indications.

诞生于上世纪90年代末的机器人辅助腹腔镜手术如今呈指数级增长。它有一些缺点,首先是成本很高,和所有新的医疗技术一样。另一方面,它的优点是非常重要的,它允许开放外科医生在恢复三维视觉的同时,将他的自然技能应用于内窥镜入路。泌尿外科是受益于这项新技术最多的专业。如果这项技术发展得像计算机一样快,它很可能与新的适应症联系在一起。
{"title":"Chirurgie urologique assistée par robot : principes généraux","authors":"J. Hubert","doi":"10.1016/j.anuro.2007.08.003","DOIUrl":"10.1016/j.anuro.2007.08.003","url":null,"abstract":"<div><p>Born in the late 90s, robotic-assisted laparoscopy has today an exponential growth. It presents some disadvantages, the first of them being a very high cost, similarly to all new medical technologies. On the other hand, its advantages are very important and allow the open surgeon to apply his natural skills to the endoscopic approach, while recovering the 3-dimensional vision. Urology is the specialty that has the most benefited from this new technology. If this technique progresses as rapidly as computers, it is likely to become associated to new indications.</p></div>","PeriodicalId":50783,"journal":{"name":"Annales D Urologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.anuro.2007.08.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27421980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Index des auteurs 作者索引
Pub Date : 2007-12-01 DOI: 10.1016/S0003-4401(07)00102-7
{"title":"Index des auteurs","authors":"","doi":"10.1016/S0003-4401(07)00102-7","DOIUrl":"https://doi.org/10.1016/S0003-4401(07)00102-7","url":null,"abstract":"","PeriodicalId":50783,"journal":{"name":"Annales D Urologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0003-4401(07)00102-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136841887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Index des mots clés 关键词索引
Pub Date : 2007-12-01 DOI: 10.1016/S0003-4401(07)00103-9
{"title":"Index des mots clés","authors":"","doi":"10.1016/S0003-4401(07)00103-9","DOIUrl":"https://doi.org/10.1016/S0003-4401(07)00103-9","url":null,"abstract":"","PeriodicalId":50783,"journal":{"name":"Annales D Urologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0003-4401(07)00103-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136841886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumeurs de novo du transplant rénal 肾移植的新肿瘤
Pub Date : 2007-12-01 DOI: 10.1016/j.anuro.2007.08.005
J.-F. Hétet , J. Rigaud , M. Dorel-Le Théo , F. Léauté , G. Karam , P. Blanchet

Kidney cancer occurs rarely and late in renal transplants. The lack of grafts and the increasing age of the cadaver donors are likely to result in an increasing number of such cancers. To date, the treatment of choice is the transplant removal. Nevertheless partial nephrectomy may be discussed in selected cases. Ultrasonographic screening should allow detection of low volume tumours suitable for partial nephrectomy. Alternative techniques (radiofrequency, cryoablation) are to be assessed in such patients.

肾移植术后很少发生肾癌,且发生较晚。移植物的缺乏和尸体捐献者年龄的增长很可能导致此类癌症的数量增加。迄今为止,首选的治疗方法是移植切除。尽管如此,在某些情况下可以讨论部分肾切除术。超声检查应能发现适合部分切除的小体积肿瘤。在这类患者中,将评估替代技术(射频、冷冻消融)。
{"title":"Tumeurs de novo du transplant rénal","authors":"J.-F. Hétet ,&nbsp;J. Rigaud ,&nbsp;M. Dorel-Le Théo ,&nbsp;F. Léauté ,&nbsp;G. Karam ,&nbsp;P. Blanchet","doi":"10.1016/j.anuro.2007.08.005","DOIUrl":"10.1016/j.anuro.2007.08.005","url":null,"abstract":"<div><p>Kidney cancer occurs rarely and late in renal transplants. The lack of grafts and the increasing age of the cadaver donors are likely to result in an increasing number of such cancers. To date, the treatment of choice is the transplant removal. Nevertheless partial nephrectomy may be discussed in selected cases. Ultrasonographic screening should allow detection of low volume tumours suitable for partial nephrectomy. Alternative techniques (radiofrequency, cryoablation) are to be assessed in such patients.</p></div>","PeriodicalId":50783,"journal":{"name":"Annales D Urologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.anuro.2007.08.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27421979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Immunosuppression en transplantation rénale 肾移植中的免疫抑制
Pub Date : 2007-12-01 DOI: 10.1016/j.anuro.2007.08.006
C. Legendre (Professeur des Universités, praticien hospitalier), J. Zuber (Chef de clinique-assistant), D. Anglicheau (Chef de clinique-assistant), M. Le Quintrec (Chef de clinique-assistant), F. Martinez (Praticien hospitalier), M.-F. Mamzer-Bruneel (Praticien hospitalier), E. Thervet (Professeur des Universités, praticien hospitalier)

Kidney transplantation has become the treatment of choice in end-stage chronic renal failure since it significantly improves both the quality of life and the life duration of affected patients, when compared with dialysis. Some of these better results that were observed over the last thirty years are obviously due to significant improvements in the quality of immunosuppression. In the first part of this chapter, the allo-immune response is schematically described regarding the various signals. Then, the mechanisms of action of the available or future immunosuppressive therapies are described in the same order as the allo-immune response. In the third part, the various combinations of immunosuppressive regimens are presented from a historical perspective, outlining not only the positive aspects of each class of drugs but also their side effects and consequences on the practical use of immunosuppression over time. Finally, a brief review of current and future perspectives regarding the improvement of both efficacy and tolerability of immunosuppression in kidney transplantation is presented.

肾移植已成为终末期慢性肾功能衰竭的治疗选择,因为与透析相比,肾移植可显著改善患者的生活质量和生存时间。在过去三十年中观察到的一些较好的结果显然是由于免疫抑制质量的显著提高。在本章的第一部分,同种免疫反应是关于各种信号的概要描述。然后,现有的或未来的免疫抑制疗法的作用机制是按照同种免疫反应的顺序描述的。在第三部分中,从历史的角度介绍了各种免疫抑制方案的组合,不仅概述了每一类药物的积极方面,而且还概述了它们的副作用和随着时间的推移对免疫抑制实际使用的后果。最后,简要回顾了目前和未来关于提高肾移植中免疫抑制的疗效和耐受性的观点。
{"title":"Immunosuppression en transplantation rénale","authors":"C. Legendre (Professeur des Universités, praticien hospitalier),&nbsp;J. Zuber (Chef de clinique-assistant),&nbsp;D. Anglicheau (Chef de clinique-assistant),&nbsp;M. Le Quintrec (Chef de clinique-assistant),&nbsp;F. Martinez (Praticien hospitalier),&nbsp;M.-F. Mamzer-Bruneel (Praticien hospitalier),&nbsp;E. Thervet (Professeur des Universités, praticien hospitalier)","doi":"10.1016/j.anuro.2007.08.006","DOIUrl":"10.1016/j.anuro.2007.08.006","url":null,"abstract":"<div><p>Kidney transplantation has become the treatment of choice in end-stage chronic renal failure since it significantly improves both the quality of life and the life duration of affected patients, when compared with dialysis. Some of these better results that were observed over the last thirty years are obviously due to significant improvements in the quality of immunosuppression. In the first part of this chapter, the allo-immune response is schematically described regarding the various signals. Then, the mechanisms of action of the available or future immunosuppressive therapies are described in the same order as the allo-immune response. In the third part, the various combinations of immunosuppressive regimens are presented from a historical perspective, outlining not only the positive aspects of each class of drugs but also their side effects and consequences on the practical use of immunosuppression over time. Finally, a brief review of current and future perspectives regarding the improvement of both efficacy and tolerability of immunosuppression in kidney transplantation is presented.</p></div>","PeriodicalId":50783,"journal":{"name":"Annales D Urologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.anuro.2007.08.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27421978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Traitement des sténoses de la jonction pyélo-urétérale par cœliochirurgie assistée par robot 机器人辅助腹腔镜手术治疗肾盂输尿管结节狭窄
Pub Date : 2007-12-01 DOI: 10.1016/j.anuro.2007.08.002
C. Egrot, J. Hubert

Since the introduction of mini-invasive surgery approximately thirty years ago, laparoscopic surgery has significantly evolved both in terms of its extended field of application and of the tools used which were diversified and improved. More recently, the development of robotic-assisted laparoscopy has brought, among other improvements, three-dimensional vision, dexterity, and a comfortable working position, which have reduced the surgeon's fatigability, the difficulties related to the operations and the learning curves of standard laparoscopy. Urology, which makes slightly less use of standard laparoscopy than general or gynaecological surgery, largely benefits from robotics concerning the precision of movements, and has much increased the operating indications of laparoscopy, including the treatment of pyelo-ureteral junction, kidney tumourectomy, living donor nephrectomy and radical prostactectomy. This chapter describes the operative technique used for the treatment of the ureteropyelic junction stenosis by robotic-assisted laparoscopy, as carried out in Nancy University Hospital with the da Vinci robot (Intuitive Surgical).

自从大约三十年前引入微创手术以来,腹腔镜手术在其扩展的应用领域和使用的多样化和改进的工具方面都有了显著的发展。最近,机器人辅助腹腔镜的发展带来了三维视觉、灵活性和舒适的工作姿势等方面的改进,这减少了外科医生的疲劳、与手术相关的困难和标准腹腔镜的学习曲线。泌尿外科与普通外科或妇科外科相比,标准腹腔镜手术的使用略少,主要得益于机器人技术在运动精度方面的优势,并大大增加了腹腔镜手术的适应症,包括肾盂输尿管连接处的治疗,肾肿瘤切除术,活体供体肾切除术和根治性前列腺切除术。本章描述了在南希大学医院使用达芬奇机器人(Intuitive Surgical)进行的机器人辅助腹腔镜治疗输尿管肾盂连接处狭窄的手术技术。
{"title":"Traitement des sténoses de la jonction pyélo-urétérale par cœliochirurgie assistée par robot","authors":"C. Egrot,&nbsp;J. Hubert","doi":"10.1016/j.anuro.2007.08.002","DOIUrl":"10.1016/j.anuro.2007.08.002","url":null,"abstract":"<div><p>Since the introduction of mini-invasive surgery approximately thirty years ago, laparoscopic surgery has significantly evolved both in terms of its extended field of application and of the tools used which were diversified and improved. More recently, the development of robotic-assisted laparoscopy has brought, among other improvements, three-dimensional vision, dexterity, and a comfortable working position, which have reduced the surgeon's fatigability, the difficulties related to the operations and the learning curves of standard laparoscopy. Urology, which makes slightly less use of standard laparoscopy than general or gynaecological surgery, largely benefits from robotics concerning the precision of movements, and has much increased the operating indications of laparoscopy, including the treatment of pyelo-ureteral junction, kidney tumourectomy, living donor nephrectomy and radical prostactectomy. This chapter describes the operative technique used for the treatment of the ureteropyelic junction stenosis by robotic-assisted laparoscopy, as carried out in Nancy University Hospital with the da Vinci robot (Intuitive Surgical).</p></div>","PeriodicalId":50783,"journal":{"name":"Annales D Urologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.anuro.2007.08.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27421981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Prostate cancer at the 2007 ASCO meeting: an urologist's perspective. 2007年ASCO会议上的前列腺癌:泌尿科医生的观点。
Pub Date : 2007-11-01
N Mottet

During the last ASCO meeting in Chicago, multiple presentations focused on prostate cancer. Several prognostic factors have been developed, either at the initial stage or early during treatment. At the localized stage, the change in prostate volume, evaluated using MRI after 2 months of hormone therapy, is a strong predictor of recurrence following the combination of radiotherapy with hormone therapy. At the metastatic hormone-refractory stage, the initial number of circulating tumour cells is of interest. Early change during chemotherapy is a strong predictor of efficacy and survival. In these patients, survival is predicted by the initial level of PSA and the time in which it doubles. The biological response is not associated with the overall survival, and therefore should not be considered as a reliable surrogate marker, leading to a new definition of response criteria for phase II trials. The EORTC trial 22961 clearly demonstrated that prolonged hormone therapy combined with radiotherapy is better than a few months of hormone therapy in locally advanced disease. This was also shown in a reanalysis of the RTOG 8531 trial. Results from prospective randomized trials on intermittent hormone treatment are growing, with a randomized trial in patients with locally advanced or metastatic disease and with a median follow up of more than 50 months. The definition of hormone-refractory status should be reconsidered with the development of new hormonal blockers. The use of Docetaxel is changing, with increasing experimental use at earlier stages. Although Atrasentan did not achieve its objectives, Satraplatin (an oral platinum salt) seems to be of interest in second line chemotherapy in a large phase 3 trial of more than 900 patients with hormone-refractory metastases.

上次在芝加哥举行的ASCO会议上,多个报告都聚焦于前列腺癌。一些预后因素已经被开发出来,无论是在初始阶段还是在治疗早期。在局部阶段,激素治疗2个月后使用MRI评估前列腺体积的变化,是放疗与激素治疗联合后复发的有力预测指标。在转移性激素难治性阶段,循环肿瘤细胞的初始数量是值得关注的。化疗期间的早期变化是疗效和生存的有力预测指标。在这些患者中,通过PSA的初始水平和翻倍的时间来预测生存。生物学反应与总生存期无关,因此不应被视为可靠的替代标志物,这导致了对II期试验反应标准的新定义。EORTC试验22961清楚地表明,在局部晚期疾病中,延长激素治疗联合放疗优于几个月的激素治疗。RTOG 8531试验的再分析也显示了这一点。间歇性激素治疗的前瞻性随机试验结果越来越多,其中一项随机试验针对局部晚期或转移性疾病患者,中位随访时间超过50个月。随着新的激素阻滞剂的发展,应重新考虑激素难治性状态的定义。多西他赛的使用正在发生变化,在早期阶段的实验性使用越来越多。尽管阿特拉森坦没有达到其目的,但在一项针对900多名激素难治性转移患者的大型3期试验中,萨特铂(一种口服铂盐)似乎对二线化疗很感兴趣。
{"title":"Prostate cancer at the 2007 ASCO meeting: an urologist's perspective.","authors":"N Mottet","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>During the last ASCO meeting in Chicago, multiple presentations focused on prostate cancer. Several prognostic factors have been developed, either at the initial stage or early during treatment. At the localized stage, the change in prostate volume, evaluated using MRI after 2 months of hormone therapy, is a strong predictor of recurrence following the combination of radiotherapy with hormone therapy. At the metastatic hormone-refractory stage, the initial number of circulating tumour cells is of interest. Early change during chemotherapy is a strong predictor of efficacy and survival. In these patients, survival is predicted by the initial level of PSA and the time in which it doubles. The biological response is not associated with the overall survival, and therefore should not be considered as a reliable surrogate marker, leading to a new definition of response criteria for phase II trials. The EORTC trial 22961 clearly demonstrated that prolonged hormone therapy combined with radiotherapy is better than a few months of hormone therapy in locally advanced disease. This was also shown in a reanalysis of the RTOG 8531 trial. Results from prospective randomized trials on intermittent hormone treatment are growing, with a randomized trial in patients with locally advanced or metastatic disease and with a median follow up of more than 50 months. The definition of hormone-refractory status should be reconsidered with the development of new hormonal blockers. The use of Docetaxel is changing, with increasing experimental use at earlier stages. Although Atrasentan did not achieve its objectives, Satraplatin (an oral platinum salt) seems to be of interest in second line chemotherapy in a large phase 3 trial of more than 900 patients with hormone-refractory metastases.</p>","PeriodicalId":50783,"journal":{"name":"Annales D Urologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27487604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Apport de l'anatomie patholosique avant et après prostatectomie totale 全前列腺切除术前后病理解剖的贡献
Pub Date : 2007-10-01 DOI: 10.1016/S0003-4401(07)80003-9
V. Moliniè , A. Descazeaud

Before radical prostatectomy, the pathologist analyzes the prostate biopsies. He has to affirm the diagnosis of cancer when present, and to provide prognosis parameters such as the Gleason score, the percentage of tumor, and to report an extraprostatic extension when present. After the radical prostatectomy, the pathologist has to analyze the surgical specimen. Two main features have to be reported including the tumor stage and the Gleason score

在根治性前列腺切除术前,病理学家分析前列腺活检。当出现时,他必须确认癌症的诊断,并提供预后参数,如Gleason评分、肿瘤百分比,当出现时,他必须报告前列腺外扩张。根治性前列腺切除术后,病理学家必须分析手术标本。必须报告两个主要特征,包括肿瘤分期和Gleason评分
{"title":"Apport de l'anatomie patholosique avant et après prostatectomie totale","authors":"V. Moliniè ,&nbsp;A. Descazeaud","doi":"10.1016/S0003-4401(07)80003-9","DOIUrl":"10.1016/S0003-4401(07)80003-9","url":null,"abstract":"<div><p>Before radical prostatectomy, the pathologist analyzes the prostate biopsies. He has to affirm the diagnosis of cancer when present, and to provide prognosis parameters such as the Gleason score, the percentage of tumor, and to report an extraprostatic extension when present. After the radical prostatectomy, the pathologist has to analyze the surgical specimen. Two main features have to be reported including the tumor stage and the Gleason score</p></div>","PeriodicalId":50783,"journal":{"name":"Annales D Urologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0003-4401(07)80003-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27284809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implants péniens. Indications et techniques 植入物peniens。适应症和技术
Pub Date : 2007-10-01 DOI: 10.1016/J.ANURO.2007.09.003
A. Faix, S.-K. Wilson
{"title":"Implants péniens. Indications et techniques","authors":"A. Faix, S.-K. Wilson","doi":"10.1016/J.ANURO.2007.09.003","DOIUrl":"https://doi.org/10.1016/J.ANURO.2007.09.003","url":null,"abstract":"","PeriodicalId":50783,"journal":{"name":"Annales D Urologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2007-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86477723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annales D Urologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1